Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)
CNY 37.71
(-1.33%)
CNY 37.71
(-1.33%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.65 CNY | 18.71% |
| 2022 | 1.39 CNY | 47.87% |
| 2021 | 0.94 CNY | 44.62% |
| 2020 | 0.65 CNY | 54.76% |
| 2019 | 0.42 CNY | 68.0% |
| 2018 | 0.25 CNY | 1068.22% |
| 2017 | 0.02 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.68 CNY | 4.62% |
| 2024 Q1 | 0.65 CNY | 441.67% |
| 2024 Q3 | 0.53 CNY | -22.06% |
| 2023 Q3 | 0.47 CNY | -25.4% |
| 2023 Q1 | 0.43 CNY | 79.17% |
| 2023 FY | - CNY | 18.71% |
| 2023 Q2 | 0.63 CNY | 46.51% |
| 2023 Q4 | 0.12 CNY | -74.47% |
| 2022 Q3 | 0.52 CNY | -23.53% |
| 2022 Q2 | 0.68 CNY | 61.9% |
| 2022 FY | - CNY | 47.87% |
| 2022 Q1 | 0.42 CNY | 16.67% |
| 2022 Q4 | 0.24 CNY | -53.85% |
| 2021 FY | - CNY | 44.62% |
| 2021 Q4 | 0.36 CNY | -16.28% |
| 2021 Q3 | 0.43 CNY | -32.81% |
| 2021 Q2 | 0.64 CNY | 166.67% |
| 2021 Q1 | 0.24 CNY | -33.33% |
| 2020 Q4 | 0.36 CNY | 111.76% |
| 2020 Q2 | 0.40 CNY | 90.48% |
| 2020 Q3 | 0.17 CNY | -57.5% |
| 2020 FY | - CNY | 54.76% |
| 2020 Q1 | 0.21 CNY | 0.0% |
| 2019 FY | - CNY | 68.0% |
| 2018 FY | - CNY | 1068.22% |
| 2017 FY | - CNY | 0.0% |